BuzzFeed: Poll shows some religious Americans are still congregating during pandemic
UC political scientist studies how many are attending religious services in the U.S. amid COVID-19
In recent weeks, many congregations have switched to online worship in response to concerns that the gatherings could spread the coronavirus. But some churches have decided to continue holding services in spite of the pandemic concerns.
Nearly one in five United States adults who consider themselves religious are still attending worship services amid concerns over the coronavirus pandemic, according to a newly released poll. The poll was conducted March 23-25 by three political scientists, including Andrew Lewis of the University of Cincinnati.
The researchers found that while 88% of respondents said that their house of worship canceled services or was closed, 17% were still attending in-person services of some kind, as reported by BuzzFeed News.
The results of the poll also appeared in the Los Angeles Times, The Christian Post and many other news outlets.
Featured image of person attending church service/Unsplash/Tyler Callahan
Related Stories
Is a colonoscopy painful?
May 13, 2026
The University of Cincinnati's Susan Kais, MD, assistant professor of clinical medicine in the Division of Gastroenterology and Hepatology in the College of Medicine and UC Health gastroenterologist, recently appeared on the ARC Cincinnati morning program on Local 12/WKRC-TV to answer common questions from viewers about colonoscopies and to dispel myths.
Telescope captures information about lonely Jupiter-like gas giant
May 13, 2026
Science outlets highlight a University of Cincinnati student's collaborative discoveries about an exoplanet 901 light years away.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.